Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
GIS.DEDay performance
| GIS.DE | |
|---|---|
| Price | 68.90 |
| Change Pct | -0.17 |
| Change Abs | -0.12 |
| Market Cap | 85.9 billion |
| Eps | 4.29 |
| Pe Ratio | 16.06 |
| Outstanding Shares | 1.2 billion |
| Volume | 1381 |
| Avg Volume | 1393 |
| Industry | Drug Manufacturers—General |
| Sector Name | Health Care |
| Country Short Name | US |
| Announcement Earnings | 2024-01-31 00:00:00+00:00 |
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
JNJ.DE
PFE.DE
MMM.DE
3 Login now
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
GIS.DE
Company descriptions
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases.